These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 8846659

  • 1. Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis.
    Geusens P.
    Clin Rheumatol; 1995 Sep; 14 Suppl 3():32-9. PubMed ID: 8846659
    [Abstract] [Full Text] [Related]

  • 2. Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?
    Johansen JS, Hassager C, Pødenphant J, Riis BJ, Hartwell D, Thomsen K, Christiansen C.
    Bone Miner; 1989 Apr; 6(1):77-86. PubMed ID: 2665884
    [Abstract] [Full Text] [Related]

  • 3. [Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].
    Gennari C, Agnusdei D, Gonnelli S.
    Minerva Endocrinol; 1989 Apr; 14(1):69-74. PubMed ID: 2659955
    [Abstract] [Full Text] [Related]

  • 4. Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis.
    Need AG, Horowitz M, Walker CJ, Chatterton BE, Chapman IC, Nordin BE.
    Bone; 1989 Apr; 10(1):3-6. PubMed ID: 2736154
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bone mineral content, cortical thickness and fracture rate in osteoporotic women after withdrawal of treatment with nandrolone decanoate, 1-alpha hydroxyvitamin D3, or intermittent calcium infusions.
    Geusens P, Dequeker J, Verstraeten A, Nijs J, Van Holsbeeck M.
    Maturitas; 1986 Dec; 8(4):281-9. PubMed ID: 3574141
    [Abstract] [Full Text] [Related]

  • 8. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
    Gennari C, AgnusDei D, Gonnelli S, Nardi P.
    Maturitas; 1989 Sep; 11(3):187-97. PubMed ID: 2687645
    [Abstract] [Full Text] [Related]

  • 9. Nandrolone decanoate for men with osteoporosis.
    Hamdy RC, Moore SW, Whalen KE, Landy C.
    Am J Ther; 1998 Mar; 5(2):89-95. PubMed ID: 10099043
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate.
    Need AG, Nordin BE, Chatterton BE.
    Osteoporos Int; 1993 Mar; 3 Suppl 1():218-22. PubMed ID: 8461566
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of nandrolone therapy on forearm bone mineral content in osteoporosis.
    Need AG, Horowitz M, Morris HA, Walker CJ, Nordin BE.
    Clin Orthop Relat Res; 1987 Dec; (225):273-8. PubMed ID: 3677513
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Prophylaxis and treatment of osteoporosis].
    Kopera H.
    Klin Wochenschr; 1989 May 15; 67(10):557-8. PubMed ID: 2739351
    [No Abstract] [Full Text] [Related]

  • 20. [Effects of nandrolone decanoate on bone mineral content and intestinal absorption of calcium].
    Nuti R, Righi GA, Turchetti V, Vattimo A.
    Minerva Med; 1984 Jan 28; 75(3-4):109-13. PubMed ID: 6366617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.